Published in J Cell Biochem on November 01, 1991
MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell (1998) 9.70
TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem (2000) 2.00
Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am J Pathol (1993) 1.08
Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes. J Cell Biol (1992) 0.94
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. Thorax (1999) 0.90
Age-related macular degeneration and changes in the extracellular matrix. Med Sci Monit (2014) 0.88
Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors. Clin Exp Metastasis (1999) 0.84
Biodegradable long-circulating polymeric nanospheres. Science (1994) 7.46
Functional arteries grown in vitro. Science (1999) 6.08
Large porous particles for pulmonary drug delivery. Science (1997) 3.35
New challenges in biomaterials. Science (1994) 2.85
Polymers for the sustained release of proteins and other macromolecules. Nature (1976) 2.81
Stimulation of neurite outgrowth using an electrically conducting polymer. Proc Natl Acad Sci U S A (1997) 2.74
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature (1992) 2.73
Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res (1991) 2.70
Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. J Biomed Mater Res (2000) 2.67
Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res (2000) 2.64
Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet (1999) 2.62
Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science (1983) 2.47
Biodegradable polymer scaffolds for tissue engineering. Biotechnology (N Y) (1994) 2.47
A controlled-release microchip. Nature (1999) 2.39
Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci U S A (1993) 2.27
Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials (1996) 2.27
Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol (1995) 2.21
Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc Natl Acad Sci U S A (1991) 2.19
Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J Orthop Res (1999) 2.19
Lipid-based nanotherapeutics for siRNA delivery. J Intern Med (2010) 2.15
Formulation and physical characterization of large porous particles for inhalation. Pharm Res (1999) 2.10
Ultrasound-mediated transdermal protein delivery. Science (1995) 2.07
Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol Prog (1998) 2.03
Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. J Am Chem Soc (2001) 2.02
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng (1999) 2.00
Transdermal photopolymerization for minimally invasive implantation. Proc Natl Acad Sci U S A (1999) 1.99
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric (2013) 1.94
Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol (2001) 1.90
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. J Pharm Sci (1980) 1.86
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg (2001) 1.84
Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol (1992) 1.79
Isolations of a cartilage factor that inhibits tumor neovascularization. Science (1976) 1.79
Identification of an inhibitor of neovascularization from cartilage. Science (1990) 1.78
Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension (2000) 1.77
Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76
Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg (1998) 1.76
Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc Natl Acad Sci U S A (2001) 1.76
Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix. J Cell Sci (1995) 1.71
The stimulation of DNA synthesis and cell division in chondrocytes and 3T3 cells by a growth factor isolated from cartilage. Exp Cell Res (1977) 1.60
A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci (1997) 1.58
Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials (1993) 1.57
Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med (2000) 1.57
Tissue engineering of cartilage in space. Proc Natl Acad Sci U S A (1997) 1.57
Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg (1988) 1.55
Transdermal photopolymerization of poly(ethylene oxide)-based injectable hydrogels for tissue-engineered cartilage. Plast Reconstr Surg (1999) 1.52
Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res (1997) 1.51
[MRI with supermagnetic iron particles versus double-spiral CT in identification of malignant liver lesions]. Rofo (1998) 1.51
Fallopian tube torsion: laparoscopic evaluation and treatment of a rare gynecological entity. J Am Board Fam Pract (2001) 1.49
Controlled and modulated release of basic fibroblast growth factor. Biomaterials (1991) 1.48
Collagen in tissue-engineered cartilage: types, structure, and crosslinks. J Cell Biochem (1998) 1.47
Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg (1991) 1.44
Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res (1993) 1.44
Bacterial inactivation by using near- and supercritical carbon dioxide. Proc Natl Acad Sci U S A (1999) 1.43
Purification and characterization of heparinase from Flavobacterium heparinum. J Biol Chem (1985) 1.43
Transdermal drug delivery using low-frequency sonophoresis. Pharm Res (1996) 1.42
Chondrogenesis in a cell-polymer-bioreactor system. Exp Cell Res (1998) 1.42
Protein stability in controlled-release systems. Nat Biotechnol (2000) 1.41
Silk based biomaterials to heal critical sized femur defects. Bone (2006) 1.40
Responsive polymeric delivery systems. Adv Drug Deliv Rev (2001) 1.40
Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc Natl Acad Sci U S A (1989) 1.39
Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors. Biomaterials (2005) 1.38
Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. Anesthesiology (1996) 1.37
Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol (1985) (1998) 1.36
Electrically conducting polymers can noninvasively control the shape and growth of mammalian cells. Proc Natl Acad Sci U S A (1994) 1.33
Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. J Biomed Mater Res (1985) 1.33
Tissue engineering: current state and perspectives. Appl Microbiol Biotechnol (2004) 1.32
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine (1994) 1.31
Biomimetic approach to cardiac tissue engineering. Philos Trans R Soc Lond B Biol Sci (2007) 1.31
A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci (1995) 1.30
Fabrication of nanostructures of polyethylene glycol for applications to protein adsorption and cell adhesion. Nanotechnology (2005) 1.30
Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Exp Cell Res (1999) 1.28
Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism. J Pharm Sci (1997) 1.27
Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res (2001) 1.27
Surface hydrolysis of poly(glycolic acid) meshes increases the seeding density of vascular smooth muscle cells. J Biomed Mater Res (1998) 1.26
A quantitative study of electroporation showing a plateau in net molecular transport. Biophys J (1993) 1.25
Modulation of the mechanical properties of tissue engineered cartilage. Biorheology (2000) 1.25
An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury. Exp Neurol (2006) 1.25
Enzymatically controlled drug delivery. Proc Natl Acad Sci U S A (1988) 1.25
AB-polymer networks based on oligo(epsilon-caprolactone) segments showing shape-memory properties. Proc Natl Acad Sci U S A (2001) 1.24
In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials (1996) 1.24
Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng (1991) 1.24
Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg (1995) 1.24
Changes in the passive electrical properties of human stratum corneum due to electroporation. Biochim Biophys Acta (1995) 1.23
Troponin I is present in human cartilage and inhibits angiogenesis. Proc Natl Acad Sci U S A (1999) 1.23
PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J Pharm Sci (1999) 1.23
Inhibition of neovascularization by an extract derived from vitreous. Am J Ophthalmol (1977) 1.23
Photopolymerizable degradable polyanhydrides with osteocompatibility. Nat Biotechnol (1999) 1.22
Responsive polymer systems for controlled delivery of therapeutics. Trends Biotechnol (1992) 1.22
Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Control Release (2001) 1.21
A re-examination of tetrodotoxin for prolonged duration local anesthesia. Anesthesiology (1998) 1.21
Magnetically enhanced insulin release in diabetic rats. J Biomed Mater Res (1987) 1.21
In vitro generation of osteochondral composites. Biomaterials (2000) 1.21
Erosion kinetics of hydrolytically degradable polymers. Proc Natl Acad Sci U S A (1993) 1.21
Gene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulate polymeric vectors. Gene Ther (2009) 1.21
Cultivation of cell-polymer cartilage implants in bioreactors. J Cell Biochem (1993) 1.20
Heparinase inhibits neovascularization. Proc Natl Acad Sci U S A (1994) 1.19